Testing a new PET scan agent for solid tumors
Part of Cancer clinical trials.
This study tests a new PET/CT imaging agent (gallium-68 FFD) to see how well it works in both healthy volunteers and people with solid tumors. It could help doctors find or monitor cancer more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are either a healthy volunteer or someone with a confirmed solid tumor.
- If you have cancer, you must be in good enough health to have a PET/CT scan (your doctor will check this).
- If you have cancer, you must have a reason for a PET/CT scan (like checking if the cancer has spread).
- You are not pregnant or breastfeeding.
- You are not allergic to the study drug (gallium).
- You have not had other cancer treatment in the last 30 days (if you have cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special imaging agent called 68Ga-GP-01 to see if it can help find cancer in people with solid tumors. You would get a PET scan before surgery to see where the cancer is.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
This trial tests a new radioactive tracer called 68Ga-SFB6-ZN01 for PET/CT scans in people with suspected or confirmed solid tumors. It aims to see if this tracer can help find cancer or detect recurrence after treatment.
This study tests a new imaging agent that lights up certain proteins on solid tumors during a PET scan. It may help doctors better see tumors and guide treatment decisions.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial tests a new type of imaging scan that uses a special tracer to help doctors see solid tumors more clearly. The scan may help improve how tumors are detected and monitored during treatment.
Hear when a new Solid Tumor Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.